MedicarePartD.guide

A non-government resource built from CMS public data

Bimzelx on Blue MedicareRx Premier (S2893-003)

bimekizumab

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 2 per 28 days.

$5,264.57
Patient pays / month
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

BIMZELX 160 mg/mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $15,953.24 for a month. Other covered strengths are listed below.

Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
FormTierPatient pays / monthLimits
BIMZELX 160 mg/mL Injection, Solution5$5,264.57PA · 2 per 28 days
BIMZELX 160 mg/mL Injection, Solution5$5,295.38PA · 2 per 28 days
BIMZELX 320 mg/2mL Injection, Solution5$11,282.23PA · 4 per 28 days
BIMZELX 320 mg/2mL Injection, Solution5$11,282.23PA · 4 per 28 days

Other IL-17 and IL-23 biologics on this plan

Verify with the plan before prescribing or filling. Member services: (888)543-4917. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s2893-003